Beta
298572

Evaluation the combination of amoxyclav with amikacin and ceftriaxone against <i>Escherichia coli</i> sepsis

Article

Last updated: 25 Dec 2024

Subjects

-

Tags

Antimicrobial resistance

Abstract

Background:  Escherichia coli (E. coli) is one of the most common causes of bloodstream infections, it is capable of gaining access to and surviving in the bloodstream are known as extra-intestinal. This research was performed to study the effect of some antibiotics on the growth of bacteria by combination with amoxiclav. Methods: The bacteria (E. coli) was isolated from bloodstream and cultured in three media (blood agar, MacConkey agar, and eosin methylene blue agar), then they were incubated for 24 hours at a temperature of 37 oC to grow. Well diffusion method is used for antibiotic sensitivity evaluation, after overnight incubation, the diameter of the inhibited growth is measured. Fifty µL of the antibiotics (ceftriaxone, amikacin, and amoxyclav) was added separately in one petri dish, and they were added in another petri dish combined with the amoxyclav, to evaluate the effect of antibiotics on the growth of bacteria before and after the addition of amoxyclav. Results: The study showed that males are more infected with 65% of the samples, and it showed that females are less infected, at 35% of the samples without significant differences (p= 0.18). The mean of inhibition zone of amikacin alone was 32.95± 5.95 that increased significantly when combined with amoxyclav 37.40± 5.36 (p= 0.018). Combination of ceftriaxone with amoxyclav showed increased in inhibition zone 43.10± 9.48 than ceftriaxone alone 39.05± 11.55 without significant differences was observed (p= 0.23). Positive strong correlation was observed between amoxyclav and amikacin (r= 0.74, p< 0.001). Conclusions: Combination of amikacin with amoxyclav has synergism effect against E. coli clinically isolated from patients with bloodstreams (p = 0.018). Addition of ceftriaxone to amoxyclav showed synergism effect but it still insignificant (p = 0.23).

DOI

10.21608/mid.2023.206746.1516

Keywords

Escherichia coli, gentamicin, Paracetamol, Sepsis, Amoxyclav

Authors

First Name

Falah

Last Name

AL-Khikani

MiddleName

Hasan Obayes

Affiliation

Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf, Iraq. Department of Microbiology, Al-Shomali General Hospital, Babylon Health Directorate, Babylon, Iraq, Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq

Email

falahgh38@gmail.com

City

-

Orcid

0000-0002-8890-7090

First Name

Haider

Last Name

Abdullah

MiddleName

Yahya

Affiliation

Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq

Email

falahgh66738@gmail.com

City

Babylon

Orcid

-

First Name

Haider

Last Name

Karkaz

MiddleName

Mahdi

Affiliation

Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq

Email

falahgh334328@gmail.com

City

-

Orcid

-

First Name

Hawraa

Last Name

abdulhussein

MiddleName

Ali

Affiliation

Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq

Email

falaher5gh38@gmail.com

City

Babylon

Orcid

-

Volume

5

Article Issue

4

Related Issue

51278

Issue Date

2024-11-01

Receive Date

2023-04-19

Publish Date

2024-11-01

Page Start

1,425

Page End

1,430

Print ISSN

2682-4132

Online ISSN

2682-4140

Link

https://mid.journals.ekb.eg/article_298572.html

Detail API

https://mid.journals.ekb.eg/service?article_code=298572

Order

18

Type

Original Article

Type Code

1,157

Publication Type

Journal

Publication Title

Microbes and Infectious Diseases

Publication Link

https://mid.journals.ekb.eg/

MainTitle

Evaluation the combination of amoxyclav with amikacin and ceftriaxone against <i>Escherichia coli</i> sepsis

Details

Type

Article

Created At

25 Dec 2024